Tag: ALS

12 articles

Research

UCSF brain-computer interface decodes speech and body gestures simultaneously from a single cortical implant

A Nature Neuroscience paper published on 14 September 2026 by Samantha C. Brosler, Jessie R. Liu, Alexander B. Silva and senior author Edward F. Chang at UCSF reports the first single-implant, single-session, real-time simultaneous decoding of speech and upper-body gestures in people with paralysis. Two of three BRAVO-trial participants (Bravo-1r, brainstem stroke, seven years enrolled; Bravo-6, ALS, implanted March 2025) controlled a personalized virtual avatar with parallel speech and gesture decoders reading from a 253-channel high-density ECoG surface array manufactured by PMT Corporation. Bravo-1r reached median 100 percent accuracy on both decoders in the real-time conversation paradigm; Bravo-6 reached 85 percent gesture and 75 percent speech. The design finding is that multimodal neural signals are not the linear sum of isolated speech and gesture signals: decoders trained on simultaneous data outperform decoders trained on isolated data, and cross-training drops opposite-modality false-positive rates from 76 percent (Bravo-1r) and 31 percent (Bravo-6) to zero. Chang has stated a fully implantable wireless successor is the next step. Hardware footprint is PMT surface ECoG plus a Blackrock Neurotech digital headstage per prior Chang-lab methods, with no overlap with Neuralink Threads, Paradromics Connexus, or Synchron Stentrode. This is the fourth UCSF Chang-lab BRAVO paper in the peer-reviewed communication-BCI sequence: Moses NEJM 2021, Metzger Nature 2023, Littlejohn Nature Neuroscience 2025, Brosler Nature Neuroscience 2026.

Sep 18

Industry News

Paradromics's first Connexus participant used a brain implant to speak her own words

Paradromics announced on 14 September 2026 that the first participant in its Connect-One Early Feasibility Study, a Michigan woman in her 60s with progressive motor neuron disease and severe dysarthria, has used the Connexus intracortical brain-computer interface to generate her own words, answer open-ended questions, and hold a live phone call with her grandchildren, three months after her June 2026 implant at University of Michigan Health. Verbatim first sentence: 'Okay, I have a lot to say.' Second sentence: 'Don't be afraid. It's a wonderful experience to be able to help others by your participation in the research study.' Both were decoded in real time, word for word, with no errors, according to Paradromics. Output modality is text plus synthesized speech (not avatar-mediated). Quantitative benchmarks (words per minute, word-error rate, vocabulary size, decoding latency) were not disclosed. The Connect-One EFS runs across three sites (University of Michigan Health, UC Davis Health, Mass General Brigham) under FDA IDE approval granted in November 2025. Same-day academic milestone at UCSF (Edward Chang team, Nature Neuroscience) demonstrates simultaneous speech and gesture decoding via animated avatar. The two results are categorically different (commercial vs academic, text-plus-audio vs avatar-mediated) and should not be conflated.

Sep 16

Industry News

ABILITY Neurotech opens Munich intraoperative BCI trial

Geneva-based ABILITY Neurotech has run a first-in-human intraoperative trial of its fully implantable brain-computer interface at TUM University Hospital in Munich, with up to five brain tumour surgery patients recorded over 20 to 30 minute sessions. A chronic ALS implant with UMC Utrecht and TU Graz is scheduled for Q4 2026. The device is an ECoG surface-electrode implant powered inductively through the scalp, using a laser-based optical link to move raw high-bandwidth neural data through intact skin, not an optical neural-sensing BCI.

Aug 22

Market Moves

Six-month-old Chinese BCI startup raises RMB 330 million angel round

Shanghai Active Technology, founded February 2026, closed a RMB 330 million angel round announced on 3 August 2026. Gasgoo and 36Kr describe the raise as the largest single angel round in the Chinese BCI sector to date, though the lead investor was not disclosed. The company is building a full-link invasive BCI with three product lines including a 1024-channel motor system called Tianshu, which has obtained a type inspection report and is preparing to launch clinical trials.

Aug 5

Industry News

Neuralink performs its first transdural implant on a Canadian ALS patient

Sgt Lee Marten of the Vancouver Police Department received a Neuralink N1 implant at Toronto Western Hospital on 20 May 2026, becoming the first Canadian ALS patient in the CAN-PRIME trial and the first human anywhere to receive the implant via Neuralink's new transdural surgical technique that preserves the dura rather than cutting it open. The story was broken by CBC News and MobiHealthNews on 2 July 2026.

Jul 4